CataCap

    Recommend CytoCT Co.

    Theme 10
    CytoCT Co.
    3 donor-investors
    Closes Mar 1, 2027

    Funding Progress

    $150,000.00 raised on CataCap toward a $600,000 goal

    3 donors have supported this

    $

    Invest: Minimum ($25000)

    You give to CataCap, a 501(c)(3). You recommend where it's invested; CataCap makes the investment, and any returns are credited to your charitable account to recommend again.

    Within Catacap$150,000
    Outside Catacap$0
    Combined funding$150,000

    About CytoCT Co.

    CytoCT is building a low-cost, point-of-care, AI-driven, cartridge-based platform for disease detection anywhere by anyone. No lab required. The initial cartridge will be used for Tuberculosis detection and contact tracing. The next cartridge will be for HIV and immune profile. Future cartridges will assess Malaria.

    Themes & SDGs Supported

    Theme 10
    Good Health and Well-Being
    Good Health and Well-Being

    Mission and Vision

    To make the diagnostic power of cytometry available to everyone, everywhere.

    Investment Terms

    To view Terms/Materials, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.

    If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.

    Investment Materials

    To view Materials/Terms, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.

    If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.

    © 2026 CataCap. All Rights Reserved.

    CataCap is a US 501(c)(3) public charity and catalytic impact investing platform, not affiliated with CataCap Management in Denmark.